Patrick Machado ’86, co-founder and former chief business and financial officer of Medivation, has been appointed to the board of directors for Endocyte, a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment. Machado is a seasoned biotech executive and experienced board member with more than 20 years of experience leading finance, business development, and legal functions.